RDHL has been in the news 536% more than usual
Sep 12, 2024, 4:32 PM
-25.09%
What does RDHL do
RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
RDHL has been in the news recently: Xeris Biopharma Holdings has a shareholder structure where individual investors hold 53% and institutions own 43%, with the top 25 shareholders controlling 40% of the company. The company is involved in various biopharma activities, indicating a strong interest in innovative therapies and industry events.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.